Kerala HC directs NDMA to formulate compensation policy for those dying due to COVID-19 vaccine
The order was passed September 1 and a time frame of three months has been set; the move sets a precedent since no such policy has been …
WHO’s updated priority pathogen list to be out by early 2023
The current list includes COVID-19, Crimean-Congo haemorrhagic fever, Ebola and Marburg
COVID-19 update: India education ministry cancels board exams for Class X
Uttar Pradesh CM Yogi Adityanath, Delhi transport minister Kailash Gehlot test positive for virus
State of India’s Environment 2021: People and planet in peril
COVID-19 may become endemic, or will continue to erupt but in limited ways in certain geographies. But its trails are already disrupting the …
West Bengal rolls out COVID-19 vaccines even as politics creeps in
Political parties blame each other of ‘vaccine theft’ in the poll-bound state
Cyclone Gati spurs locust outbreak threat in Somalia
Gati, the strongest tropical cyclone ever measured Somalia, made landfall on November 22, 2020
Recognise ASHA workers’ COVID-19 work, ensure their well-being: Report
Their experiences should be incorporated into policymaking; they should be integrated into health system, it added
COVID-19: Trump’s promise fuels anti-vaxx movement
Anti-vaccine theories inspire fear in the general population, undermining a coordinated effort to defeat the virus
First 2 phases of Russian vaccine trial indicate safety and efficacy: Study
Two formulations of the vaccine have been developed: One could be introduced through global supply chain and other in hard-to-reach regions
Why COVID-19 will not kill off global business travel
In medium term, life sciences companies will continue to expand and view travel as a vital channel for maintaining new business in markets
Book Digest: Stories of women in leadership, trends empowering them and more
From accounts of the Spanish Flu to COVID-19, DTE tracks contemporary books on development from leading authors
Cipla set to launch repurposed drug Favipiravir for COVID-19: CSIR
An off-patent anti-viral, Favipiravir was originally discovered by Fujifilm group, Japan and has shown promise in treatment of COVID-19
COVID-19: ‘Bengal hospitals turning into epicentres of novel coronavirus’
At least 80 healthcare workers, including 38 doctors, have tested positive for SARS-CoV-2 in the state
Has COVID-19 lockdown really helped Yamuna health in Delhi?
Domestic sewage comprises 80% of pollution load and continues to get discharged into the river
Democratic Republic of Congo, WHO grapple with both Ebola, COVID-19
United Nations' health arm runs short of $83 million to fight Ebola outbreak
Coronavirus versus democracy: 5 countries where emergency powers risk abuse
The global pandemic claimed its first democracy on March 30
Blocking the deadly cytokine storm is a vital weapon for treating COVID-19
The cytokine storm is a centerpiece of the COVID-19 pathology with devastating consequences for the host
In Bolivia, a model for indigenous groups grappling with COVID-19
In Bolivia, where almost half the inhabitants are of Indigenous origin, COVID-19 cases have surged
Africa’s scientists set out their COVID-19 research priorities
The pandemic is global and scientists are still trying to understand the SARS-CoV-2 virus that causes COVID-19
COVID-19: How the most vulnerable were identified in 2 Odisha districts
A non-profit working on food security issues, took up a pilot project to identify such people needing urgent governmental and non-governmental …
Rural options for Odisha’s returnee migrants
The state’s track record in engaging people under MGNREGA has been mixed so far. Hence, this huge returnee workforce must be gainfully …
India has the highest number of COVID-19 cases among its analogous countries
During the initial phase of the COVID-19 lockdown, India was the 15th worst-hit country in the world
COVID-19 and migrants: A mother abandoning her newborn shows how acute the problem is
Millions are walking on empty stomachs, suffering a sweltering summer and cold societal response
COVID-19: What did India gain in nationwide lockdown?
The country's 3-day average in number of novel coronavirus disease (COVID-19) cases is currently at 3,060; with it being 76 when the lockdown began
Coronavirus: surprisingly big problems caused by small errors in testing
There is as much controversy as there is excitement about giving antibody teststo those who test positive for having had the disease